EHang Appoints KPMG Huazhen LLP as its Independent Registered Public Accounting Firm

EHang dismissed PwC and engaged KPMG Huazhen as its independent registered public accounting firm effective August 19, 2026, for the fiscal year ending Dec. 31, 2026 and internal controls over financial reporting as of Dec. 31, 2026. PwC’s prior audit reports for 2024 and 2025 were unqualified, with no adverse opinion or disclaimer. While there’s no immediate audit red flag, the auditor change is a mild cautionary signal that could affect investor confidence.

Analysis

The main mechanism here is not the auditor switch itself, but what it says about the next leg of capital formation for a pre-profit, regulation-sensitive name. For a company like EH, confidence is the product: any perceived friction in audit continuity can widen the discount rate investors apply, even if there is no immediate accounting issue. That matters most on the equity story, not near-term operations, because the business still depends on repeated capital access and a credibility premium to fund certification, production, and international expansion.

Second-order, this is more negative for the multiple than for the operating model. Competitors with cleaner U.S. reporting profiles and less jurisdictional overhang — notably JOBY and ACHR as liquid U.S. proxies — can gain relative appeal if allocators reduce exposure to China-linked governance risk. If KPMG’s first year closes cleanly, the issue can fade within 1-3 months; if there is any delay, control weakness language, or filing slippage, the market will likely reprice the name on governance alone, regardless of headline growth metrics.

The contrarian view is that the move may be overread if investors assume auditor changes always imply trouble. Sometimes the real signal is simply a company upgrading process support or aligning with a more globally accepted auditor ahead of a tougher reporting cycle. The falsifier is straightforward: on-time 2026 filings, no material weakness disclosure, and no change in financing terms would argue the discount is too large; conversely, any 10-K delay or adverse ICFR language would validate a more defensive stance over the next 1-2 quarters.

Key Decisions for Investors

• Avoid adding to EH for now; wait for the first KPMG-audited filing cycle and internal-control language before underwriting a rerating. Time horizon: 1-3 months. Risk/reward is poor until disclosure quality is proven.
• If already long EH, hedge event risk with 1-2 month out-of-the-money puts into the next filing window. This is a lower-cost way to protect against a control-disclosure surprise or filing delay.
• Relative-value: prefer long JOBY/ACHR versus EH on any sympathy weakness. Time horizon: 1-6 months. Thesis is that U.S.-listed peers with cleaner governance should command a higher multiple as allocators de-risk China-linked AAM exposure.
• Set an alert for any 2026 filing delay, material weakness disclosure, or financing announcement from EH; those would be the actionable triggers to increase the short bias. If filings are clean, cover the hedge and reassess.